This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chabielska, E. Articles by Buczko, W. Search for Related Content PubMed PubMed Citation Articles by Chabielska, E. Articles by Buczko, W. Social Bookmarking                         What's this?

The involvement of AT2-receptor in the antithrombotic effect of losartan in renal hypertensive rats

Department of Pharmacodynamics, Medical Academy, Mickiewicza Str. 2C, 15-230 Bialystok, Poland, chabewa@ poczta.onet.pl

Tomasz Matys

Department of Pharmacodynamics, Medical Academy, Mickiewicza Str. 2C, 15-230 Bialystok, Poland

Iwona Kucharewicz

Department of Pharmacodynamics, Medical Academy, Mickiewicza Str. 2C, 15-230 Bialystok, Poland

Dariusz Pawlak

Department of Pharmacodynamics, Medical Academy, Mickiewicza Str. 2C, 15-230 Bialystok, Poland

Roland Rólkowski

Department of Laboratory Diagnostics, Regional Centre of Oncology, Bialystok, Poland

Wlodzimierz Buczko

Department of Pharmacodynamics, Medical Academy, Mickiewicza Str. 2C, 15-230 Bialystok, Poland

In previous studies, we have shown that losartan possesses nitric oxide-dependent antithrombotic properties in various models of hypertension in rats. It was demonstrated that stimulation of AT₂-receptors plays an important role in the pharmacological effects of AT₁-receptor antagonists. Thus, in this study, we examine the participation of AT₂-receptors in the antithrombotic action of losartan in renal hypertensive rats on venous thrombosis induced by a two-hour ligation of the vena cava. Losartan administration (30 mg/kg, p.o.) resulted in a marked decrease in thrombus weight (by 85%, p<0.001). PD123319, an AT₂-receptor antagonist (10 mg/kg, i.v.), administered concomitantly with losartan, abolished its antithrombotic effect, whilst it had no influence on thrombus weight when given alone. A significant decrease in systolic blood pressure was observed in animals given losartan. PD123319 administration did not abolish this action of losartan and did not alter blood pressure when given alone. No changes in prothrombin time, activated partial thromboplastin time, or euglobulin clot lysis time were observed in animals administered losartan and/or PD123319. Similarly, primary haemostatics evaluated by bleeding time and platelet count did not change in any group of rats. In conclusion, we have shown that AT₂receptor stimulation is involved in the antithrombotic action of losartan in renal hypertensive rats.

Key Words: AT2—receptor • losartan • thrombosis • rat

References

• Vaughan DE, Lazos SA,Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest 1995;95:9951001.
• Ridker PM, Gaboury CL, Conlin PR, Seely EW,Williams GH, Vaughan DE Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 1993; 87: 1969-73.[Abstract/Free Full Text]
• Feener EP, Northrup JM,Aiello LP, King GL Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995; 5:1353-62.
• Nishimura H., Tsuji H., Masuda H. et al. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost 1997; 77: 1189-95.[Web of Science][Medline] [Order article via Infotrieve]
• Ding YA, MacIntyre DE, Kenyon Ch, Semple P. Potentiation of adrenaline-induced platelet aggregation by angiotensin II. Thromb Haemost 1985; 54: 717-20.[Web of Science][Medline] [Order article via Infotrieve]
• Pastore L.,TessitoreA.,Martinotti S. et al.Angiotensin II stimulates intracellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999; 100: 1646-52.[Abstract/Free Full Text]
• Timmermans Pbmwm, Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharm Rev 1993; 45: 205-51.[Web of Science][Medline] [Order article via Infotrieve]
• Johnston CI Angiotensin receptor antagonists: focus on losartan. Lancet 1995; 346:1403-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Goldberg MR, Tanaka W., Barchowsky A. et al. Effects of losartan on blood pressure, plasma renin activity and angiotensin II in volunteers. Hypertension 1993; 21: 704-13.[Abstract/Free Full Text]
• Stoll M., Steckelings UM, Paul M., Bottari SP, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95: 651-7.[Web of Science][Medline] [Order article via Infotrieve]
• Levy BI, Benessiano J., Henrion D. et al. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996; 98: 418-25.[Web of Science][Medline] [Order article via Infotrieve]
• Wiemer G., Scholkens BA, Bosse R., Wagner A., Heitsch H., Linz W. The functional role of angiotensin II-subtype AT2-receptor in endothelial cells and isolated ischemic rat hearts. Pharm Pharmacol Lett 1993; 3: 24-7.
• Seyedi N., Xu X., NasjlettiA, Hintze TH Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995; 26: 164-70.[Abstract/Free Full Text]
• Tsutsumi Y., Matsubara H., Masaki H. et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilatation. J Clin Invest 1999; 104(7): 925-35.[Web of Science][Medline] [Order article via Infotrieve]
• Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993; 70: 36-41.[Web of Science][Medline] [Order article via Infotrieve]
• Chabielska E., Pawlak R., Golatowski J., Rólkowski R., Pawlak D., Buczko W. Losartan inhibits the experimental venous thrombosis in spontaneously hypertensive rats. Thromb Res 1998; 90: 271-78.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chabielska E., Pawlak R., Wollny T., Rólkowski R., Buczko W. Antithrombotic activity of losartan in two kidney, one clip hypertensive rats. A study on the mechanism of action. J Physiol Pharmacol 1999; 50: 99-109.[Medline] [Order article via Infotrieve]
• Reyers I., De Gaetano G., Donati MB Venostasis-induced thrombosis in rat is not influenced by circulating platelet or leukocyte number.AgentsActions 1989; 28: 137-40.
• Ikeda K., Nara Y.,Yamori Y. Indirect systolic and mean blood pressure determination by a new tail cuff method in spontaneously hypertensive rats. Lab Animals 1991; 25: 26-9.[Abstract/Free Full Text]
• Dejana E., Villa S., De Gaetano G. Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemost 1982; 48: 108-11.[Web of Science][Medline] [Order article via Infotrieve]
• De Gasparo M., Husain A., Alexander W. et al. Proposed update of angiotensin receptor nomenclature. Hypertension 1995; 25: 924-7.[Free Full Text]
• Nio Y., Matsubara H., Murasawa S., Kanasaki M., Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995; 95:46-54.[Web of Science][Medline] [Order article via Infotrieve]
• Haywood GA, Gullestad L., Katsuya T. et al. AT1- and AT2receptor gene expression in human heart failure. Circulation 1997; 95: 1201-6.[Abstract/Free Full Text]
• Ohkubo N., Matsubara H., NozawaY. et al.Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 1997; 96: 3954-62.[Abstract/Free Full Text]
• Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.J Clin Invest 1997; 99:1926-35.[Web of Science][Medline] [Order article via Infotrieve]
• JalowyA, Schulz R., Dörge H., Behrends M., Heusch G. Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandin in pigs. J Am Coll Cardiol 1998; 32: 1787-96.[Abstract/Free Full Text]
• Scheuer DA, Perrone MH Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol 1993; 264: R917-R923.[Web of Science][Medline] [Order article via Infotrieve]
• Lidbury PS, Korbut R., Vane JR Sodium nitroprusside modulates the fibrinolytic system in the rabbit. Br J Pharmacol 1990; 101: 527-30.[Web of Science][Medline] [Order article via Infotrieve]
• Korbut R., Lidbury PS,Vane JR Prolongation of fibrinolytic activity of tissue plasminogen activator by nitrovasodilators. Lancet 1990; 335:669-70.[CrossRef][Medline] [Order article via Infotrieve]
• Hogan JC, Lewis MJ, HendersonAH In vivo EDRF activity influences platelet function. Br J Pharmacol 1988; 94: 1020-2.[Web of Science][Medline] [Order article via Infotrieve]
• Kubes P., Suzuki M., Granger DN Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci 1991; 88: 4651-55.[Abstract/Free Full Text]
• De Caterina R., Libby P., Peng HB et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-8.[Web of Science][Medline] [Order article via Infotrieve]
• Campbell DJ, Kladis A., Valentijn AJ Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J Cardiovasc Pharmacol 1995; 26: 233-40.[Web of Science][Medline] [Order article via Infotrieve]
• Brosnihan KB, Li P., Ferrario CM Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996; 27: 523-8.[Abstract/Free Full Text]
• Kucharewicz I., Chabielska E., Pawlak D., Matys T., Buczko W. The role of angiotensin-(1-7) in the antithrombotic action of losartan. JRAAS 2000; 1: 94.
• Jaiswal N., Diz DI, Tallant A., Khosla MC, Ferrario CM The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis.AmJHypertens 1991; 4: 228-33.[Web of Science][Medline] [Order article via Infotrieve]
• Liu ECK, Hedberg A., Goldenberg DN, Harris DN, Weed ML DUP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet A2 prostaglandin H2 (TP) receptors. Prostaglandins 1992; 44: 89-99.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Li P., Ferrario CM, Bronsnihan KB Losartan inhibits Thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1998; 32: 198-205.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Seljeflot I., Moan A., Kjeldsen S., Sandvic E., Arnesen H. Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension. Hypertension 1996; 27: 1299-304.[Abstract/Free Full Text]
• Barber MN, Sampey DB,Widdop RE AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension 1999; 34: 1112-6.[Abstract/Free Full Text]
• Siragy HM, Carey RM Protective role of the angiotensin AT2-receptor in a renal wrap hypertension model. Hypertension 1999; 33: 1237-42.[Abstract/Free Full Text]
• Gigante B., Piras O., De Paolis P., Porcellini A., Natale A.,Volpe M. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats. J Hypertens 1998; 16: 2039-43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pawlak R., Chabielska E., Golatowski J.,AzzadinA, Buczko W. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats. Thromb Haemost 1998; 79:1208-12.[Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 3, 263-267 (2000)
DOI: 10.3317/jraas.2000.040


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chabielska, E. Articles by Buczko, W. Search for Related Content PubMed PubMed Citation Articles by Chabielska, E. Articles by Buczko, W. Social Bookmarking                         What's this?